|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| NTAP | De Lorenzo Daniel | VP, Controller & CAO | Dec 01 '25 | Sale | 110.04 | 33 | 3,631 | 0 | Dec 03 04:26 PM |
| NTAP | DANIEL DE LORENZO | Officer | Dec 01 '25 | Proposed Sale | 110.04 | 33 | 3,631 | Dec 01 04:07 PM | |
| NTAP | De Lorenzo Daniel | VP, Controller & CAO | Nov 17 '25 | Sale | 107.48 | 327 | 35,146 | 0 | Nov 19 04:16 PM |
| NTAP | DANIEL DE LORENZO | Officer | Nov 17 '25 | Proposed Sale | 107.48 | 327 | 35,146 | Nov 17 04:01 PM | |
| NTAP | De Lorenzo Daniel | VP, Controller & CAO | Sep 25 '25 | Sale | 121.87 | 779 | 94,937 | 0 | Sep 29 04:30 PM |
| NTAP | DANIEL DE LORENZO | Officer | Sep 25 '25 | Proposed Sale | 121.87 | 779 | 94,937 | Sep 25 04:13 PM | |
| NTAP | De Lorenzo Daniel | VP, Controller & CAO | Jun 03 '25 | Sale | 98.77 | 302 | 29,829 | 455 | Jun 05 04:30 PM |
| NTAP | DANIEL DE LORENZO | Officer | Jun 03 '25 | Proposed Sale | 98.77 | 302 | 29,829 | Jun 03 04:04 PM | |
| NTAP | De Lorenzo Daniel | VP, Controller & CAO | May 16 '25 | Sale | 99.98 | 326 | 32,593 | 455 | May 19 04:30 PM |
| NTAP | DANIEL DE LORENZO | Officer | May 16 '25 | Proposed Sale | 99.98 | 326 | 32,593 | May 16 04:07 PM | |
| NTAP | De Lorenzo Daniel | VP, Controller & CAO | Feb 19 '25 | Sale | 121.28 | 299 | 36,263 | 0 | Feb 21 04:15 PM |
| NTAP | De Lorenzo Daniel | VP, Controller & CAO | Nov 18 '24 | Sale | 117.44 | 326 | 38,285 | 0 | Nov 19 06:13 PM |
| NTAP | DANIEL DE LORENZO | Officer | Nov 18 '24 | Proposed Sale | 117.44 | 326 | 38,285 | Nov 18 04:25 PM | |
| NTAP | De Lorenzo Daniel | VP, Controller & CAO | Sep 24 '24 | Sale | 123.60 | 1,685 | 208,266 | 0 | Sep 26 04:15 PM |
| NTAP | DANIEL DE LORENZO | Officer | Sep 24 '24 | Proposed Sale | 123.60 | 1,685 | 208,266 | Sep 24 04:04 PM | |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite